Searchable abstracts of presentations at key conferences in endocrinology

ea0011p135 | Clinical case reports | ECE2006

The effects of lanreotide administration vs unilateral adrenalectomy on disease activity in gip-dependent cushing’s syndrome

Robaczyk M , Krzyzanowska-Swiniarska B , Kulig G , Pilarska K

GIP-dependent Cushing’s syndrome (CS) is caused by ectopic expression in adrenal cortex of gastric inhibitory peptide (GIP) receptors coupled to steroidogenesis, which leads to postprandial increases of cortisol (food-dependent CS). In a few cases a transient effect of short-acting octreotide on cortisol levels has been shown, but bilateral adrenalectomy is still thought to be a definitive treatment.We report on a case of a 45-year old woman with bi...

ea0029p1631 | Thyroid (non-cancer) | ICEECE2012

Thyroid function in large elderly population – results of multicenter study performed in Poland

Bar-Andziak E. , Milewicz A. , Jedrzejuk D. , Arkowska A. , Mieszczanowicz U. , Krzyzanowska -Swiniarska B. , Sierdzinski J.

Multidimensional studies of medical aspects of ageing were performed in 6 provinces of Poland, the protocol included cross sectional analysis of thyroid function parameters.The sample was randomly chosen and included 4,051 respondents (49.2% females).Group consisted of 3,502 elderly subjects aged 65–90+y, divided into approximately equal six age subgroups; and 549 younger cohort, aged 55–59 y.Thyroi...

ea0011p408 | Diabetes, metabolism and cardiovascular | ECE2006

Elevated serum hs-CRP in the obese – still much to be explained

Koziolek M , Krzyzanowska-Swiniarska B , Robaczyk M , Szczerkowska A , Kempa A , Kulig G , Andrysiak-Mamos E , Pilarska K

Obesity is considered as a state of chronic, systemic low-grade inflammation. Likely causes include infectious factors, leptin, cigarette smoking, low serum HDL-cholesterol and high serum triglycerides. No definitive confirmation on the causative factor is available so far.The aim of the study was to evaluate serum levels of C-reactive protein (hs-CRP, sensitivity 0,085 ng/L), IL-6, IL-10, TNF-α and its soluble type 2 receptor (sTNF-αR-2) in vi...

ea0016p525 | Obesity | ECE2008

Abdominal fat and atheromatosis risk factors in non-obese healthy subjects

Bednarek-Tupikowska Grazyna , Kubicka Eliza , Tworowska-Bardzinska Urszula , Lenarcik Agnieszka , Matczak-Giemza Magdalena , Milewicz Andrzej , Krzyzanowska-Swiniarska Barbara , Katra Barbara

In the 1980s the concept, that some individuals with normal weight (Metabolically Obese, Normal-Weight) have disturbances of metabolism, related to obesity was proposed. It is known, that obesity promotes atheromatosis by various mechanism, inter alia due to excess of inflammatory markers. This problem however, was not investigated in non-obese subjects.We analyzed anthropometric variables, body fat distribution by DXA and serum CRP, Il-6 and Il-18 in 43...

ea0029p224 | Calcium & Vitamin D metabolism | ICEECE2012

Obesity, carbohydrate, lipid metabolism and polymorphisms (Fok, Bsm) of vitamin D receptor gene in aging population: POLSENIOR study

Milewicz A. , Laczmanski L. , Puzianowska-Kuznicka M. , Jedrzejuk D. , Pawlak M. , Kolackov K. , Chudek J. , Arkowska A. , Mieszczanowicz U. , Krzyzanowska-Swiniarska B. , Bar-Andziak E.

Pleiotropic effects of vit. D in the etiology of obesity, metabolic syndrome and diabetes are still debated. So far published reports considered only changes in vit D plasma level in individuals with obesity and diabetes, and did not take into account the role of polymorphisms in the vit. D receptor gene.The aim of the study was to evaluate obesity, carbohydrate and lipid metabolism and vitamin D level in two VDR polymorphisms (Fok and Bsm) in Polish agi...

ea0029p231 | Calcium & Vitamin D metabolism | ICEECE2012

Markers of bone turnover and polymorphism of vitamin D receptor gene in aging population: POLSENIOR study

Jedrzejuk D. , Milewicz A. , Laczmanski L. , Puzianowska-Kuznicka M. , Pawlak M. , Kolackov K. , Arkowska A. , Mieszczanowicz U. , Krzyzanowska-Swiniarska B. , Bar-Andziak E.

The levels of bone turnover markers are elevated e.g. in osteoporosis, neoplastic diseases with bone involvement (e.g. myeloma). Recently bone markers have been found to play an important role in other diseases, like cardiovascular diseases (CVD). Vitamin D, which plays a role in body metabolism, is also an important hormone maintaining bone homeostasis.The aim of the study was to evaluate the levels of bone turnover markers (osteoprotegerin and ICTP) in...

ea0011p316 | Diabetes, metabolism and cardiovascular | ECE2006

Endothelial, inflammatory and endocrine markers in women with PCOS before and after metformin treatment

Heutling D , Schulz H , Nickel I , Kleinstein J , Kaltwasser P , Randeva HS , Krzyzanowska K , Mittermayer F , Wolzt M , Schernthaner G , Lehnert H

Polycystic ovary syndrome (PCOS) affects more than 5% of women in reproductive age and is characterized by a heterogeneous spectrum of oligoanovulation and biochemical or clinical evidence of hyperandrogenism. Insulin resistance and compensatory hyperinsulinaemia play a significant role in pathogenesis of PCOS.Chronic low level inflammation and an increased risk for cardiovascular disease and type2-diabetes are reported in women with PCOS.<p class="a...

ea0035p381 | Diabetes (epidemiology, pathophysiology) | ECE2014

Changes of sphingolipid profiles in serum of patients with diabetes

Siewko Katarzyna , Car Halina , Fiedorowicz Anna , Maciulewski Rafal , Zielinska Anna , Poplawska-Kita Anna , Krzyzanowska-Grycel Edyta , Chabowski Adrian , Zendzian-Piotrowska Malgorzata , Lipinska Danuta , Milewska Anna , Gorska Maria , Szelachowska Malgorzata

Ceramide (Cer) and sphingomyelin (SM) belong to a family of sphingolipids (SLs). Both SLs are mixtures of many species, differed in length and saturation of the fatty acid chain. Cer and SM are important components of the plasma membrane. In addition, Cer is a cellular second messenger, mediating apoptosis. The altered profiles of blood plasma/serum SLs were found in many pathologies. Interestingly, circulating SLs were proposed to be the early predictors of Alzheimer disease....

ea0070aep596 | Pituitary and Neuroendocrinology | ECE2020

Efficacy and safety of long-acting pasireotide (LA-PAS) in patients with uncontrolled acromegaly: Results from the prospective cohort of european observational acronis study

Pivonello Rosario , Tabarin Antoine , Colao Annamaria , Kaltsas Gregory , Gonzalez-Molero Inmaculada , Neggers Sebastian , Venegas Moreno Eva , Kocjan Tomaz , Karges Wolfram , Krzyzanowska-Mittermayer Katarzyna , Heck Ansgar , Eden Engstrom Britt , Marques Ruben , O’Brien Eamonn , Manne Shobha , Vincenzi Beatrice , Schöfl Christof

Introduction: Results of the first European real-world evidence from retrospective cohort of ACRONIS study previously confirmed the efficacy and tolerability of LA-PAS in heavily pre-treated, uncontrolled acromegaly patients. Here, we report results of the second interim analysis reflecting the prospective cohort.Methods: Patients who were treated with LA-PAS for ≥6 months were included in this analysis. The primary objective was to document treatm...

ea0070aep866 | Thyroid | ECE2020

Radioactive Iodine-Refractory (RAI) Differentiated Thyroid Cancer (rDTC): Analysis of the Canadian Patient Support Program (PSP) for the Prescription and Treatment Patterns of Lenvatinib (LEN)

Boucher Andree , Hortensia Mircescu , Geneviève Rondeau , Rebecca Leboeuf , Bernard Lemieux , Maryse Brassard , Marie-Hélène Massicotte , monika Krzyzanowska , Dean Ruether , Nathaniel Bouganim , Nathan Lamond , Shereen Ezzat , Eric Winquist , Scott Laurie , Neil Chua , Paul Klimo , Howard Lim , Ralph Wong , Ramji Zahra , Alexander Flint , Hauck Wendy , Sebastien Hotte

Differentiated thyroid carcinoma (DTC) is viewed as an indolent disease but 5–15% of patients (pts) become refractory to RAI treatment. This is associated with poor prognosis, a 3–6 years life expectancy and accounts for approximately 200 deaths per year in Canada. There is no universal definition of rDCT and management evolves over time, with either monitoring or systemic therapy including LEN. In the Select Study on LEN in DTC, LEN provided a 19.4 month (mo) medi...